MOUNTAIN VIEW, Calif., Feb. 7, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, announced today that it intends to file an appeal to overturn the court’s ruling denying Conceptus’ motion for permanent injunction against Hologic Inc.'s Adiana system. In addition, Hologic has today filed an appeal of the jury’s patent validity and infringement verdict.
